ANRO
ANRO
US02157Q1094
Alto Neuroscience, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
66.364.000 68.610.000
3.3%
Operating Income -66.364.000 -68.610.000
3.3%
Pretax Income -63.238.000 -61.431.000
2.9%
Net Income Common Stockholders -63.238.000 -61.431.000
2.9%
-- --
--
-- --
--
ende